Sofosbuvir-Based Therapy in the Pre-Liver Transplant Setting: The Canadian National Experience.

CONCLUSIONS: SOF-based therapy for patients progressing to liver transplantation leads to high SVR rates, short term stability in liver function, and deactivation from the transplant list. PMID: 31103148 [PubMed - in process]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research